Bill Sponsors: NJ S1667 | 2022-2023 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-02-14 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S1667 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Senator Troy Singleton [D]PrimarySponsored BillsSD-007FollowTheMoneyBallotpediaVoteSmart

Social Comments on NJ S1667

feedback